P SHERRILL NEFF
CIK 1189158 · last filed 2026-03-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$561.5K
Companies
6
Total Filings
35
Lifetime Open-Market Net
$9.10M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACR | Director | 31,006 | $18.11 | $561.5K | $0 | 13 | 2026-03-06 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 2,529,642 | — | — | $8.99M | 8 | 2016-10-07 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 1 | 2015-01-06 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Director | 143,780 | — | — | $287.2K | 2 | 2014-01-03 |
| ACRES Commercial Realty Corp. (RSO) Delisted | Director | 6,939 | — | — | -$181.1K | 7 | 2012-03-14 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 1,419,762 | $14.49 | $20.57M | $0 | 4 | 2010-06-17 |
Recent Filings · Page 2 of 4
35 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-05 | MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-10 | ACR | Grant (A) | +8,583 | $0 | EDGAR |
| 2015-01-06 | Tobira Therapeutics, Inc. (TBRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-02 | MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-11 | ACR | Grant (A) | +6,872 | $0 | EDGAR |
| 2014-01-10 | MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-03 | Tobira Therapeutics, Inc. (RGDO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-08-29 | Tobira Therapeutics, Inc. (RGDO) Delisted | Mixed | +1,258,093 | $287.2K | EDGAR |
| 2013-08-01 | MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Buy (P) | +265,000 | $1.85M | EDGAR |
| 2013-03-14 | ACR | Grant (A) | +2,615 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.